Boerner Christopher S.'s Form 4 filing
Bristol Myers Squibb Co (BMY) · filed Mar 16, 2022
- Accession no.
- 0000014272-22-000087
- Filed
- Mar 16, 2022
- Trade date
- Mar 14, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $2.04M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boerner Christopher S.CIK 0001543747 | Officer (EVP, Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2022 | Common Stock, $0.10 par value | SSaleDisposed | −29,532 | $69.20 | −$2,043,614.4 | 41,966 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.